Our enthusiasm is high as we join forces with Medidata to continue our unwavering commitment towards advancing clinical research and fostering business growth for sponsors. We are proud to implement Medidata’s cloud-based clinical solutions – Rave EDC, Rave RTSM, and Rave Imaging which will further augment our clinical trial efficiency by automating and streamlining data management workflows, and securely delivering higher-quality data for faster insights.
Lambda Therapeutics Research is a leading Global Clinical Research Organization (CRO) headquartered in Ahmedabad, India, with a strong presence in North America (USA and Canada) and Europe (London and Warsaw, Poland). With over two decades of experience, Lambda Therapeutics Research is a trusted name for providing comprehensive end-to-end clinical research services to the global innovator, biotech, and generic pharmaceutical industries. The organization provides a comprehensive range of clinical trial services, including patient-based trials for late-phase clinical efficacy and safety, early phase development, NCE trials, biosimilar assay development labs for large molecule drugs, data management, drug safety and pharmacovigilance, and medical imaging.
The implementation allows both Lambda & Medidata (a Dassault Systemes company) to offer their global clients a single unified platform that optimizes workflows, mitigates risk, cuts development costs, and secures data integrity.
Rave Imaging’s intelligent workflows simplify image and data collection and are configured to immediately perform edit checks and de-identification during the image upload process. The system then automates the distribution and review process after upload as per the protocol design. Rave Imaging’s structured approach to image submission simplifies workflows and improves efficiency, reducing the time and cost associated with image management while increasing data quality and confidence.
By unifying Rave Imaging with EDC, both collect critical data to support the management of clinical trials by bringing the two data collection environments together for an integrated data platform that saves time, resources and costs. RTSM is built on Rave EDC, without double data entry and with minimal reconciliation that expedite study start-up and study close out.
“As Lambda Therapeutics positions itself for growth globally, we needed a data management solution that can keep up with our needs. Medidata’s solutions will enable us to enhance clinical trials and research timelines and strengthen our competitive advantage globally,” said Mrs. Bindi Chudgar, Founder & Managing Director, Lambda Therapeutics Research.
“Technology, such as AI and cloud enabled solutions, greatly enhance clinical trial efficiency. As the industry continues to move clinical trials out of lab settings, Medidata’s solutions have transformed the clinical trials industry by allowing life science and medical device organizations to cut development costs, mitigate risks, and deliver treatments and devices to market faster,” said Edwin Ng, Senior Vice President, Asia Pacific, Life Science, Dassault Systemes
Lambda has consistently allocated substantial resources towards adopting cutting-edge technology, aimed at offering our clients enhanced data visibility that facilitates better decision-making. Our collaborative efforts aim to aid sponsors in conducting trials that are highly efficient, impactful, and easily scalable.
About Lambda Therapeutic Research:
Lambda Therapeutic Research (India, UK, and Poland) and Novum Pharmaceutical Research Services (USA and Canada) are top-tier CROs providing comprehensive end-to-end clinical research services to the global innovator, biotech, and generic pharmaceutical industries.
